Commonwealth Bank (CBA)
|
|
- Ruby French
- 5 years ago
- Views:
Transcription
1 10 February 2016 Analyst TS Lim Authorisation Chris Savage Commonwealth Bank (CBA) Ordeal and triumph Recommendation Buy (unchanged) Price $74.20 Target (12 months) $83.50 (previously $85.50) Expected Return Capital growth 12.5% Dividend yield 5.7% Total expected return 18.2% Company Data & Ratios Enterprise value Market cap n/m $126,700m Issued capital 1,708m Free float 100% Avg. daily val. (52wk) $302.6m 12 month price range $ $96.27 GICS sector Price Performance Banks (1m) (3m) (12m) Price (A$) Absolute (%) Rel market (%) Strong underlying 1H16 despite the odds CBA s headline 1H16 results are as follows: (1) reported NPAT $4,618m (BP $4,784m, consensus $4,764m); (2) cash NPAT $4,804m (BP $4,770m, consensus $4,773m); (3) cash EPS 285cps (BP 287cps, consensus 285cps); (4) interim dividend 198cps fully franked (BP 202cps, consensus 198cps); (5) neutral Jaws pcp (BP neutral Jaws pcp); (6) ROE 17.2% (BP 17.2%); (7) CET1 10.2% (BP 10.2%, consensus 10.4%); (8) Group NIM 2.06% (BP 2.07%, consensus 2.10%); and (9) BDD charge $564m or 17bp of GLA (BP $519m or 17bp, consensus $522m or 16bp). CBA s 1H16 results were largely in line with expectations. Cash NPAT increased by 4% on a pcp basis to $4.8bn (+6% hoh), reflecting strong revenue growth (+6% pcp, +5% hoh) and cost discipline (+6% pcp, +3% hoh) the key ingredients in sustaining underlying profitability. Jaws was neutral on a pcp basis but improved to +2% in the last six months. The figure excluding FX was +1.2% on a pcp basis (5% revenue growth and 3.8% expense growth) and we expect this to be higher on an underlying basis. Underlying profit (excluding the BDD charge) improved by 6% on a pcp basis (also 6% hoh) to $7.2bn. The smaller difference of $186m between reported and cash NPAT is due to larger hedging and IFRS volatility, i.e. higher unrealised losses on economic hedges. CBA maintained its 198cps interim dividend (on a pcp basis, despite the dilution impact from its August capital raising) and its target dividend payout ratio of around 70% in the first half and around 80% in the second half. Price target $83.50, Buy rating maintained Our estimate changes reflect lower other income and higher BDD net of lower operating expenses. The net result is a slight decrease to cash NPAT and cash EPS across the forecast horizon of 2%. Consistent with lower EPS expectations, we have also trimmed the dividend estimates and the price target is slightly lowered to $83.50 (previously $85.50). Today s results highlight CBA s resilience and the availability of multiple value levers to pull in a challenging market Buy rating maintained. Absolute Price $100 $95 $90 $85 $80 $75 $70 $65 Feb 14 Jun 14 CBA Oct 14 Feb Jun Oct S&P 300 Rebased Earnings Forecast Year end 30 June e 2017e 2018e NPAT (reported) (A$m) 9,063 9,533 10,064 10,620 NPAT (adjusted) (A$m) 9,137 9,569 10,100 10,656 EPS (adjusted) (A ps) EPS growth (%) 5% 0% 4% 4% PER (x) P/Book (x) P/NTA (x) Dividend (A ps) Yield (%) 5.7% 5.7% 5.8% 6.1% ROE (%) 18.2% 16.6% 15.9% 15.6% NIM (%) 2.09% 2.06% 2.05% 2.05% Franking (%) 100.0% 100.0% 100.0% 100.0% SOURCE: IRESS SOURCE: BELL POTTER SECURITIES ESTIMATES BELL POTTER SECURITIES LIMITED ACN AFSL DISCLAIMER AND DISCLOSURES THIS REPORT MUST BE READ WITH THE DISCLAIMER AND DISCLOSURES ON PAGE 12 THAT FORM PART OF IT. Page 1
2 Ordeal and triumph Strong underlying 1H16 despite the odds CBA s headline 1H16 results are as follows: Reported NPAT $4,618m (BP $4,784m, consensus $4,764m); Cash NPAT $4,804m (BP $4,770m, consensus $4,773m); Cash EPS 285cps (BP 287cps, consensus 285cps); Interim dividend 198cps fully franked (BP 202cps, consensus 198cps); Neutral Jaws pcp (BP neutral Jaws pcp); ROE 17.2% (BP 17.2%); CET1 10.2% (BP 10.2%, consensus 10.4%); Group NIM 2.06% (BP 2.07%, consensus 2.10%); and BDD charge $564m or 17bp of GLA (BP $519m or 17bp, consensus $522m or 16bp). CBA s 1H16 results were largely in line with expectations. Cash NPAT increased by 4% on a pcp basis to $4.8bn (+6% hoh), reflecting strong revenue growth (+6% pcp, +5% hoh) and cost discipline (+6% pcp, +3% hoh) the key ingredients in sustaining underlying profitability. Jaws was neutral on a pcp basis but improved to +2% in the last six months. The figure excluding FX was +1.2% on a pcp basis (5% revenue growth and 3.8% expense growth) and we expect this to be higher on an underlying basis. Underlying profit (excluding the BDD charge) improved by 6% on a pcp basis (also 6% hoh) to $7.2bn. The smaller difference of $186m between reported and cash NPAT is due to larger hedging and IFRS volatility, i.e. higher unrealised losses on economic hedges. NIE increased by 6% on a pcp basis (+6% hoh) to $8.4bn, largely driven by strong volume effect (and stable rate effect hoh). While NIM fell by 5bp on a pcp basis to 206bp and the spread was roughly unchanged at 194bp, the more important factor in our view is the change in the six months to 31 December. At the Group level, the spread improved by 1bp and NIM was stable at 206bp with the difference being a 1bp lower free fund effect (impacted by a low rate environment). Group spread and NIM were favourably impacted by repricing in the Australian operations (spread unchanged pcp and +1bp hoh, NIM -2bp pcp and +5bp hoh). We note mortgage repricing in Australia only took place in November and there should be some tailwind from full repricing in the second half. The table below highlights the changes in spread and NIM in Australia after netting out a notional transfer price/charge. While the table indicates asset competition and a higher 90 day bank bill rate crimping the loan spread in 1H16, we expect some of this pressure to ease when the full mortgage repricing benefit takes effect. More surprisingly, the Australian division reported positive funding spreads compared with the substantial negative funding spreads at the time of the GFC (1H09). Table 1 CBA Australian spread and NIM analysis CBA (Australia) 1H08 2H08 1H09 2H09 1H10 2H10 1H11 2H11 1H12 2H12 1H13 2H13 1H14 2H14 1H15 2H15 1H16 Average loan yield 7.21% 7.72% 7.65% 6.12% 5.85% 6.45% 6.80% 6.96% 6.70% 6.44% 5.95% 5.74% 5.41% 5.26% 5.12% 4.87% 4.60% Average deposit cost 4.80% 5.46% 5.42% 3.77% 3.48% 4.22% 4.41% 4.58% 4.35% 4.09% 3.56% 3.30% 2.95% 2.74% 2.65% 2.37% 2.10% Average other funding cost 6.45% 6.68% 5.94% 3.44% 3.53% 3.95% 4.61% 4.28% 4.42% 4.27% 3.67% 3.57% 3.05% 2.97% 2.96% 2.67% 2.26% 90 day BBSW 7.29% 7.81% 4.39% 3.25% 4.13% 4.89% 5.03% 4.99% 4.51% 3.49% 3.11% 2.79% 2.61% 2.69% 2.77% 2.14% 2.35% Loan spread -0.08% -0.09% 3.26% 2.87% 1.72% 1.56% 1.78% 1.97% 2.19% 2.95% 2.84% 2.96% 2.81% 2.57% 2.35% 2.73% 2.25% Deposit spread 2.49% 2.35% -1.03% -0.52% 0.65% 0.67% 0.62% 0.41% 0.16% -0.60% -0.45% -0.52% -0.35% -0.05% 0.12% -0.23% 0.25% Other funding spread 0.84% 1.13% -1.55% -0.19% 0.60% 0.94% 0.42% 0.71% 0.09% -0.78% -0.56% -0.79% -0.45% -0.28% -0.19% -0.53% 0.09% Net spread 3.25% 3.39% 0.68% 2.16% 2.97% 3.17% 2.81% 3.09% 2.44% 1.57% 1.83% 1.66% 2.02% 2.24% 2.28% 1.97% 2.59% Geographic spread 1.86% 1.72% 1.79% 2.04% 2.08% 1.99% 1.90% 1.99% 1.89% 1.81% 1.84% 1.98% 2.03% 2.05% 2.04% 2.03% 2.04% Geographic NIM 2.13% 1.99% 2.06% 2.21% 2.29% 2.18% 2.19% 2.31% 2.17% 2.10% 2.11% 2.20% 2.18% 2.19% 2.17% 2.10% 2.15% Page 2
3 Other banking income increased by 4% on a pcp basis to $2.5bn (unchanged hoh). While commissions and lending fees were up strongly (pcp and hoh) and in line with volume growth, these were offset by lower trading income (lower treasury earnings and unfavourable derivative valuation adjustments on a pcp and hoh basis, and lower asset sales and a loss on New Zealand earnings hedge on a hoh basis). Offsetting the latter and lower investment experience (impacted by market volatility) were strong performances in funds management (higher net FUA and FUM) and insurance income (new volumes, repricing and lower claims and lapse experience). Operating expenses increased by 6% on a pcp basis to $5.2bn (+3% hoh), driven by inflation-related SAW increases (+6% pcp and hoh) including the impact of a weaker A$, higher occupancy and equipment expenses (+4% pcp, +2% hoh) due to rental reviews and a weaker A$, and higher IT expenses (+20% pcp, +13% hoh) largely related to risk and compliance projects. These were offset by lower general costs (-2% pcp, -14% hoh) reflecting lower professional fees and non-lending losses. The cost-to-income ratio was unchanged at 42% on a pcp basis (1.1% improvement on a hoh basis) while the banking component improved from 39.3% in 1H15 to 39.0% in 2H15 and 38.6% in 1H16. Efficiency gains at Group level are also reflected in costs as a percentage of average assets (1.20% in 1H15, 1.18% in 2H15 and 1.17% in 1H16). At least the market cannot blame CBA for relying on a lower BDD charge this time around to boost the bottom line. The BDD charge increased by 28% on a pcp basis to $564m (+3% hoh) reflecting higher Retail Banking Services arrears (WA and QLD mining towns and personal lending), higher volume-driven collective charges in Business and Private Banking, higher individual provisions in Institutional Banking and Markets and higher commercial lending provisions in International. The overall BDD charge was however largely unchanged at 17bp of GLA, confirming our views that any increase towards the through-the-cycle charge of 20-30bp would be gradual and thus manageable. Gross impaired assets were unchanged at $2.8bn since 30 June while total provisions in relation to impaired assets and GLA were unchanged at around 37% and 0.55% respectively. Overlays are unchanged and CBA s overall credit quality remains in good order. Figure 1 Credit quality sound SOURCE: COMPANY DATA Page 3
4 We expected a higher dividend and this was also a function of our higher EPS estimate. In the end, CBA maintained its 198cps interim dividend (on a pcp basis, despite the dilution impact from its August capital raising) and maintained its target dividend payout ratio of around 70% in the first half and around 80% in the second half (around 75% on a full year basis). Organic capital generation remains strong excluding higher APRA credit RWA requirements covered by the capital raising, net organic capital generation in 1H16 was +17bp. APRA CET1 capital ratio of 10.2% translates into 14.3% on a harmonised basis, and this ranks CBA at third place among its global peers. Figure 2 Ahead of the pack SOURCE: COMPANY DATA Funding capability continues to be strong with deposit funding improving to 64% of total funding ( %) and incremental lending ($30bn) again largely funded by incremental deposits ($22bn) in 1H16. The average wholesale funding tenor has been maintained at 3.9 years while liquidity coverage further improved to 123% of total net cash outflows (120% in 2H15, 116% in 1H15). Figure 3 Strong prudentials SOURCE: COMPANY DATA Page 4
5 The variance analysis is highlighted in Table 1. Table 2 Broadly in line with our expectations Commonwealth Bank Y/E 30 June ($m) 1H16 BP Variance Comments Net interest income 7,531 7,332 3% Better volume growth on top of stable NIM Other income 3,891 3,909 0% Broadly in line with expectations Total operating income 11,422 11,242 2% Broadly in line with expectations Operating expenses -4,826-4,704-3% Higher risk/compliance spend and branch refurbishment costs Impairment expenses % Mix of higher IB&M collective provisions and lower write-backs Net profit before income tax 6,016 6,019 0% Broadly in line with expectations Corporate tax expense -1,642-1,692 3% Function of NPBT Minority interests % Broadly in line with expectations Bankwest % Sale of NVN units, investment gains and assumption changes Investment experience Large Non-recurrence of divestment benefits and revaluation gains NPAT (cash basis) 4,804 4,770 1% Broadly in line with expectations DPS (cps) % Broadly in line with expectations EPS (cash basis) (cps) % Broadly in line with expectations NIM 2.06% 2.07% -0.01% Broadly in line with expectations ROE 17.3% 17.2% 0.2% Broadly in line with expectations Underlying earnings (ex-bdd) 6,596 6,538 1% Broadly in line with expectations On a quarterly basis (Figures 4 and 5), growth again has been maintained since 2Q12 based on positive Jaws (absolute and underlying). The six-month trends (Table 3) remain healthy and include a significant improvement in ROA. Figure 4 Maintaining underlying earnings momentum Figure 5 based on positive Jaws 3.0 CBA quarterly earnings 35% Growth in CBA quarterly earnings 30% % % ($bn) % 10% 1.0 5% 0.5 0% -5% 0.0 3Q10 4Q10 1Q11 2Q11 3Q11 4Q11 1Q12 2Q12 3Q12 4Q12 1Q13 2Q13 3Q13 4Q13 1Q14 2Q14 3Q14 4Q14 1Q15 2Q15 3Q15 4Q15 1Q16 2Q16-10% 3Q10 4Q10 1Q11 2Q11 3Q11 4Q11 1Q12 2Q12 3Q12 4Q12 1Q13 2Q13 3Q13 4Q13 1Q14 2Q14 3Q14 4Q14 1Q15 2Q15 3Q15 4Q15 1Q16 2Q16 Cash earnings Underlying earnings Cash earnings Underlying earnings Table 3 Six-monthly trends Group KPIs 1H08 2H08 1H09 2H09 1H10 2H10 1H11 2H11 1H12 2H12 1H13 2H13 1H14 2H14 1H15 2H15 1H16 Growth in NIE 4% 5% 32% 41% 21% 3% 0% 10% 12% 5% 3% 9% 8% 8% 6% 3% 6% Growth in total income 4% 6% 24% 23% 10% 2% 2% 6% 4% 1% 2% 5% 7% 6% 6% 6% 6% Growth in operating expenses 4% 8% 19% 16% 6% 3% 3% 3% 4% 2% -3% -1% 5% 4% 5% 7% 6% Growth in PBT before BDD 3% 4% 29% 30% 14% 2% 0% 8% 3% 0% 5% 10% 9% 7% 7% 5% 6% Growth in loans 8% 5% 30% 31% 8% 6% 2% 2% 6% 6% 4% 5% 6% 6% 6% 7% 8% Growth in deposits 12% 2% 35% 30% -3% 5% 9% 6% 6% 4% 2% 4% 9% 8% 9% 12% 8% NIM 2.06% 1.98% 1.99% 2.16% 2.18% 2.08% 2.12% 2.17% 2.13% 2.05% 2.11% 2.15% 2.16% 2.12% 2.11% 2.06% 2.06% Cost ratio 48% 49% 46% 46% 45% 47% 45% 46% 46% 46% 44% 43% 43% 43% 42% 43% 42% Cost / average assets 1.48% 1.52% 1.45% 1.36% 1.37% 1.36% 1.36% 1.36% 1.34% 1.29% 1.24% 1.23% 1.22% 1.20% 1.20% 1.18% 1.17% Tier 1 capital ratio 8.2% 8.2% 8.8% 8.1% 9.1% 9.1% 9.7% 10.0% 9.9% 10.0% 10.3% 10.3% 10.6% 11.1% 11.6% 11.2% 12.2% Impairment expense / GLA 0.19% 0.33% 0.87% 0.61% 0.57% 0.28% 0.29% 0.22% 0.21% 0.20% 0.23% 0.17% 0.16% 0.17% 0.14% 0.17% 0.17% Total provisions + GRCL / RWA 0.70% 0.85% 1.51% 1.92% 1.98% 1.88% 1.92% 1.83% 1.71% 1.60% 1.49% 1.36% 1.28% 1.16% 1.10% 0.99% 0.94% ROE 20.8% 19.1% 14.0% 16.1% 18.6% 18.8% 19.3% 19.8% 19.3% 18.0% 18.1% 18.4% 18.8% 18.7% 18.6% 17.7% 17.3% ROA 1.05% 0.98% 0.69% 0.78% 0.94% 0.99% 1.03% 1.06% 1.04% 1.00% 1.04% 1.09% 1.11% 1.12% 1.13% 1.05% 1.08% Page 5
6 Key segment comments Retail Banking Services (RBS) (positive outcome) RBS remains a key value driver for CBA. Cash NPAT increased by 8% on a pcp basis to $2,215m (+14% hoh) based on strong revenue growth (+7% pcp, +8% hoh) including better NIM (estimated at +3bp pcp, +12bp hoh), better other income, cost discipline (+4% pcp, +2% hoh) including flat costs as a percentage of footings and positive Jaws throughout, and a lower BDD charge. Table 4 Six-monthly trends RBS 1H08 2H08 1H09 2H09 1H10 2H10 1H11 2H11 1H12 2H12 1H13 2H13 1H14 2H14 1H15 2H15 1H16 Market share - Home loans 9.8% 10.1% 10.5% 11.8% 12.6% 12.8% 12.9% 12.9% 11.2% 11.1% 11.1% 11.4% 11.9% 11.9% 11.9% 12.0% 12.1% - Consumer loans 0.6% 0.6% 0.6% 0.6% 0.7% 0.7% 0.7% 0.7% 0.7% 0.8% 0.8% 0.8% 0.7% 0.7% 0.7% 0.7% 0.7% - Deposits 11.2% 11.3% 11.9% 11.5% 12.0% 12.2% 12.1% 12.1% 11.1% 11.0% 11.3% 11.2% 12.0% 11.8% 12.0% 12.0% 12.1% NIM n/a 2.28% 2.35% 2.23% 2.35% 2.17% 2.25% 2.37% 2.46% 2.38% 2.51% 2.53% 2.59% 2.60% 2.68% 2.59% 2.71% Other income / footings 0.22% 0.22% 0.22% 0.21% 0.17% 0.16% 0.16% 0.15% 0.18% 0.17% 0.17% 0.17% 0.18% 0.17% 0.17% 0.16% 0.17% Operating expense / footings 0.43% 0.42% 0.39% 0.38% 0.35% 0.34% 0.33% 0.34% 0.37% 0.35% 0.35% 0.34% 0.34% 0.32% 0.32% 0.31% 0.31% Cost ratio 45% 47% 42% 43% 39% 40% 39% 39% 40% 40% 38% 37% 36% 34% 34% 35% 33% Impairment expense / loans 0.08% 0.10% 0.11% 0.19% 0.15% 0.13% 0.09% 0.11% 0.14% 0.09% 0.10% 0.11% 0.11% 0.10% 0.09% 0.12% 0.10% Effective tax rate 30% 30% 30% 29% 31% 29% 30% 29% 29% 30% 30% 30% 30% 30% 30% 30% 30% Business and Private Banking (B&PB) (positive outcome) This is another key value driver for CBA. Cash NPAT increased by 5% on a pcp basis to $803m (+10% hoh) based on strong revenue growth (5-6% growth pcp and hoh) and cost discipline (3-4% growth pcp and hoh). Credit quality was stable and estimated NIM improved by 3bp on a pcp basis and by 8bp on a hoh basis. Institutional Banking and Markets (IB&M) (neutral outcome) The market s worst fears were unrealised with cash NPAT just down slightly to $608m (-6% pcp, -4% hoh) due to higher BDD charges (mix of higher individual and collective provisions net of recoveries and lower write-backs) and unfavourable derivative value adjustments offsetting positive markets sales flows and trading income. Table 5 Six-monthly trends B&PB / IB&M 1H08 2H08 1H09 2H09 1H10 2H10 1H11 2H11 1H12 2H12 1H13 2H13 1H14 2H14 1H15 2H15 1H16 Market share - Loans 6.7% 6.5% 7.0% 6.6% 6.4% 6.3% 6.0% 6.0% 8.2% 8.2% 8.1% 8.3% 8.0% 8.0% 8.0% 8.2% 8.2% - Other IEA 1.2% 1.0% 1.5% 1.7% 1.5% 1.5% 1.8% 1.6% 1.7% 1.6% 1.6% 1.6% 2.2% 1.9% 1.0% 1.2% 1.2% - IBL 12.5% 11.8% 12.2% 10.3% 9.8% 10.0% 9.8% 10.0% 12.1% 11.7% 11.3% 11.3% 11.2% 10.9% 9.3% 10.2% 10.2% NIM n/a 1.65% 1.91% 1.92% 1.93% 1.93% 1.95% 1.92% 2.15% 2.17% 2.07% 2.05% 1.92% 1.82% 2.11% 2.03% 1.98% Other income / footings 0.34% 0.37% 0.33% 0.36% 0.48% 0.43% 0.44% 0.43% 0.24% 0.22% 0.27% 0.26% 0.26% 0.24% 0.27% 0.24% 0.23% Operating expense / footings 0.32% 0.35% 0.31% 0.35% 0.38% 0.39% 0.37% 0.38% 0.29% 0.28% 0.29% 0.29% 0.27% 0.28% 0.29% 0.28% 0.28% Cost ratio 43% 44% 39% 39% 37% 41% 39% 40% 35% 36% 35% 36% 36% 38% 36% 38% 38% Impairment expense / AIEA 0.12% 0.18% 0.82% 0.44% 0.34% 0.04% 0.21% 0.17% 0.08% 0.12% 0.12% 0.09% 0.04% 0.09% 0.08% 0.07% 0.09% Effective tax rate 26% 18% -12% 19% 22% 28% 27% 26% 27% 26% 27% 27% 27% 28% 28% 26% 26% Wealth Management (positive outcome) Cash NPAT was 7% higher on a pcp basis to $372m (+22% hoh). A better insurance outcome (better volumes, repricing, lower lapses and lower claims) and a turnaround in platform contributions more than offset subdued results in funds management (spot AUM 2% higher on a pcp basis or -3% hoh to $195bn but overall result impacted by investment market volatility). Table 6 Six-monthly trends Wealth 1H08 2H08 1H09 2H09 1H10 2H10 1H11 2H11 1H12 2H12 1H13 2H13 1H14 2H14 1H15 2H15 1H16 Growth in FUA 24% 10% -21% -9% 18% 6% 3% 5% -4% 2% 19% 25% 12% 5% 30% 32% 3% Funds management return 0.63% 0.59% 0.57% 0.47% 0.51% 0.50% 0.53% 0.52% 0.51% 0.50% 0.41% 0.39% 0.35% 0.34% 0.32% 0.28% 0.29% Growth in insurance income 0% 0% 26% 11% 8% 1% -4% -14% 7% 15% -24% -19% 1% 11% -2% -22% 20% Volume expenses / TOI 18% 18% 19% 21% 20% 20% 19% 21% 22% 20% 22% 23% 23% 24% 23% 29% 23% Growth in operating expenses 0% 0% 5% -5% -1% 2% 3% 9% 10% 4% -27% -29% -2% 3% 5% 21% 5% Effective tax rate 28% 26% 27% 31% 28% 24% 27% 27% 26% 27% 27% 26% 23% 25% 26% 20% 28% Page 6
7 New Zealand (positive outcome) Cash NPAT in NZ$ terms was 4% higher on a pcp basis to NZ$515m (+7% hoh), driven by strong revenue growth across banking, funds management and insurance, effective cost management and a better BDD outcome more than offsetting some NIM softness. Table 7 Six-monthly trends New Zealand 1H08 2H08 1H09 2H09 1H10 2H10 1H11 2H11 1H12 2H12 1H13 2H13 1H14 2H14 1H15 2H15 1H16 NIM % 1.50% 1.77% 1.83% 2.08% 2.12% 2.17% 2.16% 2.29% 2.32% 2.43% 2.30% 2.25% Other income / footings % 0.10% 0.14% 0.15% 0.12% 0.12% 0.14% 0.13% 0.13% 0.12% 0.13% 0.13% 0.15% Operating expense / footings % 0.37% 0.39% 0.41% 0.38% 0.41% 0.35% 0.36% 0.36% 0.36% 0.36% 0.35% 0.34% Cost ratio % 56% 52% 53% 47% 49% 43% 44% 43% 42% 40% 40% 39% Impairment expense / AIEA % 0.00% 0.06% 0.06% 0.02% 0.05% 0.04% 0.04% 0.03% 0.05% 0.05% 0.07% 0.05% Effective tax rate % 20% 23% 24% 24% 25% 24% 25% 25% 24% 25% 25% 27% Bankwest (neutral outcome) Cash NPAT was flat on a pcp basis at $396m (-1% hoh) with top line growth impacted by lower volumes from a slowing WA economy and price competition. The positives relate to cost discipline (flat operating expenses) and a lower BDD charge given ongoing net write-back. Table 8 Six-monthly trends Bankwest 1H08 2H08 1H09 2H09 1H10 2H10 1H11 2H11 1H12 2H12 1H13 2H13 1H14 2H14 1H15 2H15 1H16 Market share - Home loans % 1.8% 2.0% 2.1% 2.2% 2.3% 2.4% 2.4% 2.4% 2.4% 2.5% 2.6% 2.5% 2.6% 2.5% - Consumer loans % 1.4% 1.4% 1.3% 1.2% 1.1% 1.1% 1.1% 1.0% 0.9% 0.9% 0.8% 0.8% 0.7% 0.7% - Deposits % 5.3% 5.5% 5.5% 5.2% 5.1% 3.2% 3.1% 2.7% 2.6% 2.6% 2.7% 2.6% 2.7% 2.6% NIM % 1.97% 2.07% 2.04% 2.02% 2.19% 2.17% 1.97% 2.07% 2.13% 2.18% 2.05% 2.16% 2.11% 2.10% Other income / footings % 0.14% 0.09% 0.08% 0.09% 0.07% 0.09% 0.08% 0.10% 0.09% 0.09% 0.09% 0.09% 0.08% 0.08% Operating expense / footings % 0.39% 0.34% 0.32% 0.32% 0.32% 0.37% 0.35% 0.36% 0.36% 0.35% 0.33% 0.32% 0.30% 0.30% Cost ratio % 64% 57% 55% 54% 52% 50% 52% 48% 47% 45% 46% 42% 42% 41% Impairment expense / loans % 0.18% 0.48% 0.65% 0.07% 0.09% 0.05% 0.03% 0.12% 0.04% 0.01% 0.01% -0.03% -0.03% -0.02% Effective tax rate % 31% 32% 31% 30% 30% 30% 30% 30% 30% 30% 31% 30% 30% 30% Price target $83.50, Buy rating maintained Our estimate changes (Table 11, next page) reflect lower other income and higher BDD net of lower operating expenses. The net result is a slight decrease to cash NPAT and cash EPS across the forecast horizon of 2%. Consistent with lower EPS expectations, we have also trimmed the dividend estimates and the price target is slightly lowered to $83.50 (previously $85.50). Today s results highlight CBA s resilience and the availability of multiple value levers to pull in a challenging market Buy rating maintained. Table 9 Composite valuation Composite Valuation Value ($m) Per share Weighting Composite value per share DCF 154,745 $ % $36.25 Dividend yield (sustainable) 134,120 $ % $31.42 ROE (sustainable) 133,600 $ % $7.82 Sum-of-Parts 137,411 $ % $8.05 Total $83.54 Table 10 SOP valuation Sum-of-Parts (As Is) 2017e NPAT Pros. PE (times) Value ($m) Per share Retail Banking 4, ,009 $36.90 B&PB / IB&M 3, ,841 $23.92 Wealth Management ,605 $6.80 New Zealand 1, ,357 $8.41 BankWest & Other ,600 $4.45 Total 10, ,411 $80.47 Page 7
8 Table 11 Estimate changes Commonwealth Bank 2016e 2017e 2018e 2019e Y/e June 30 ($m) Current Previous Change Current Previous Change Current Previous Change Current Previous Change Profit & Loss Net interest income 15,191 14,870 2% 15,658 15,665 0% 16,375 16,423 0% 17,213 17,215 0% Other income 7,783 7,905-2% 8,205 8,395-2% 8,639 8,888-3% 9,090 9,413-3% Total operating income 22,973 22,775 1% 23,863 24,060-1% 25,014 25,312-1% 26,303 26,628-1% Operating expenses -9,685-9,513-2% -9,641-9,732 1% -9,838-9,995 2% -10,034-10,262 2% Impairment expenses -1,202-1,056-12% -1,443-1,233-15% -1,655-1,437-13% -1,869-1,646-12% Net profit before income tax 12,087 12,206-1% 12,779 13,095-2% 13,521 13,880-3% 14,400 14,720-2% Corporate tax expense -3,360-3,435 2% -3,555-3,681 4% -3,764-3,900 4% -4,012-4,133 3% BankWest % % % % Investment experience, etc % % % % NPAT (cash basis) 9,569 9,668-1% 10,100 10,331-2% 10,656 10,903-2% 11,311 11,539-2% DPS (cps) % % % % EPS (cash basis) (cps) % % % % ROE 16.6% 16.7% -0.1% 15.9% 16.2% -0.3% 15.6% 15.9% -0.3% 15.5% 15.7% -0.2% NIM 2.06% 2.07% -0.02% 2.05% 2.08% -0.04% 2.05% 2.09% -0.04% 2.06% 2.09% -0.03% Cost ratio 42.1% 41.8% -0.3% 40.4% 40.5% 0.1% 39.4% 39.6% 0.2% 38.3% 38.7% 0.4% Impairment expense as % of GLA 0.18% 0.16% -0.01% 0.21% 0.19% -0.02% 0.23% 0.22% -0.02% 0.26% 0.24% -0.02% Page 8
9 CBA Profile Company description CBA is Australia s leading integrated financial services organisation, providing banking and wealth management (funds management, superannuation, insurance and investment advice) products and services to over 10m customers. It currently occupies pole positions in home lending and retail deposits. The bank s strategic strengths of scale, brand and diversified mix is supported by an irreplaceable infrastructure consisting of 1,150+ branches, 3,800 Australia Post agencies, 3,300 ATMs and 155,000 merchant relationships. Investment strategy CBA s strategy is built upon continuous service and sales improvement backed by IT and operational excellence, and a leadership position in retail banking. Incremental value add is expected to come from opportunities in the SME banking, ECM / DCM and wealth management space (particularly in advice, private banking and life risk where the market is 80% underinsured) and selective Asian expansion (East Asia, Indonesia and Singapore). Valuation The price target is roughly based on a composite valuation weighted as follows. In CBA s case, this is more closely aligned to the DCF and sustainable dividend yield play values as earnings continue to normalise post the GFC and capital raising. The bank is viewed as a consistent yield story. Table 12 Composite valuation Composite Valuation Value ($m) Per share Weighting Composite value per share DCF 154,745 $ % $36.25 Dividend yield (sustainable) 134,120 $ % $31.42 ROE (sustainable) 133,600 $ % $7.82 Sum-of-Parts 137,411 $ % $8.05 Total $83.54 Table 13 SOP valuation Sum-of-Parts (As Is) 2017e NPAT Pros. PE (times) Value ($m) Per share Retail Banking 4, ,009 $36.90 B&PB / IB&M 3, ,841 $23.92 Wealth Management ,605 $6.80 New Zealand 1, ,357 $8.41 BankWest & Other ,600 $4.45 Total 10, ,411 $80.47 SWOT analysis Strengths 1. Retail banking (sales and service) and wealth management expertise; 2. Strong management and execution capabilities; 3. Low risk banking assets; 4. Scale in all aspects of diversified financial services and IT capabilities; and 5. Access to high level government and regulatory contacts in China, opening doors to further expansion opportunities. Page 9
10 Weaknesses 1. Ongoing liquidity drag that is a systemic issue. Opportunities 1. Rationalising BankWest; 2. Value add from ECM / DCM opportunities in capitalising on the bank s AA- rating and balance sheet strength; 3. Leveraged to an underinsured Australian life risk and GI market; 4. Offshore banking and wealth opportunities, e.g. Europe and US; and 5. Leveraged to wealth management and strength of NSW economy. Threats 1. Macroeconomic factors such as higher unemployment and slowing credit growth; 2. Changes in regulatory environment, especially the potential capping of fees that would crimp earnings growth; 3. Disruptors; 4. Negative fallout from financial planning review; 5. Bank re-regulation; and 6. Some sovereign risk exposed to sometimes unstable governments in Asia. Sensitivities Table 14 Sensitivities Y/e June e 2017e 2018e 2019e 2020e 2021e 2022e 2023e 2024e Sensitivities Group NIM +10bp NPAT upside (cash basis) 5.4% 5.3% 5.3% 5.2% 5.1% 5.1% 5.1% 5.1% 5.1% - Price target upside $4.46 $4.38 $4.33 $4.27 $4.22 $4.20 $4.21 $4.20 $4.19 Group Loans +1% NPAT upside (cash basis) 0.7% 0.7% 0.7% 0.7% 0.7% 0.7% 0.7% 0.7% 0.7% - Price target upside $0.61 $0.62 $0.61 $0.61 $0.61 $0.61 $0.61 $0.61 $0.61 RBS loans +1% NPAT upside (cash basis) 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% - Price target upside $0.39 $0.38 $0.38 $0.38 $0.38 $0.38 $0.39 $0.39 $0.39 B&PB/IB&M loans +1% NPAT upside (cash basis) 0.3% 0.3% 0.3% 0.3% 0.3% 0.3% 0.3% 0.3% 0.3% - Price target upside $0.25 $0.25 $0.25 $0.25 $0.25 $0.24 $0.24 $0.24 $0.24 NZ loans +1% NPAT upside (cash basis) 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% - Price target upside $0.08 $0.08 $0.08 $0.08 $0.08 $0.08 $0.08 $0.08 $0.08 Other income +1% NPAT upside (cash basis) 0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6% - Price target upside $0.47 $0.47 $0.47 $0.46 $0.46 $0.46 $0.47 $0.47 $0.47 BDD +1% NPAT upside (cash basis) -0.1% -0.1% -0.1% -0.1% -0.1% -0.1% -0.1% -0.1% -0.1% - Price target upside -$0.07 -$0.08 -$0.09 -$0.10 -$0.10 -$0.10 -$0.10 -$0.11 -$0.11 Costs +1% NPAT upside (cash basis) -0.7% -0.7% -0.6% -0.6% -0.6% -0.6% -0.6% -0.6% -0.6% - Price target upside -$0.58 -$0.55 -$0.53 -$0.51 -$0.50 -$0.50 -$0.50 -$0.50 -$0.50 Page 10
11 Commonwealth Bank as at 10 February 2016 Recommendation Buy Price $74.20 Target (12 months) $83.50 Commonwealth Bank (CBA) 10 February 2016 Table 15 Financial summary Commonwealth Bank of Australia Share Price (A$) As at 10-Feb-16 Market Cap (A$M) 126,700 PROFIT AND LOSS VALUATION DATA Y/e June 30 ($m) e 2017e 2018e Y/e June e 2017e 2018e Net interest income 13,514 14,107 15,191 15,658 16,375 NPAT (cash basis) ($m) 8,680 9,137 9,569 10,100 10,656 Other banking income 4,117 4,657 4,808 5,071 5,348 EPS (statutory basis) (cps) Total banking income 17,631 18,764 19,998 20,730 21,723 - Growth 13% 4% 1% 4% 4% Funds management income 1,796 1,938 2,083 2,182 2,290 EPS (cash basis) (cps) Insurance income ,001 - Growth 11% 5% 0% 4% 4% Total operating income 20,246 21,494 22,973 23,863 25,014 P / E ratio (times) Operating expenses -8,622-9,206-9,685-9,641-9,838 P / Book ratio (times) Impairment expenses ,038-1,202-1,443-1,655 P / NTA ratio (times) Net profit before income tax 10,682 11,250 12,087 12,779 13,521 Net DPS (cps) Corporate tax expense -2,902-3,038-3,360-3,555-3,764 Yield 5.4% 5.7% 5.7% 5.8% 6.1% Minority interests Franking 100% 100% 100% 100% 100% BankWest NPAT (cash basis) Payout (cash basis) 75% 75% 75% 74% 74% Investment experience NPAT (cash basis) 8,680 9,137 9,569 10,100 10,656 CAPITAL ADEQUACY Adjustments Y/e June e 2017e 2018e NPAT (statutory basis) 8,631 9,063 9,533 10,064 10,620 Risk weighted assets ($m) 337, , , , ,948 Average risk weight 44% 44% 49% 52% 52% CASHFLOW Tier 1 ratio 11.1% 11.2% 11.5% 11.3% 11.6% Y/e June 30 ($m) e 2017e 2018e Core Tier 1 ratio 9.3% 9.1% 9.7% 9.6% 10.0% NPAT (cash basis) 8,680 9,137 9,569 10,100 10,656 Total capital ratio 12.0% 12.7% 13.2% 12.8% 13.0% Equity ratio 6.2% 6.1% 6.7% 6.9% 7.0% Increase in loans -35,157-43,951-36,380-34,359-36,227 Increase in other assets 2,805-31,137-14,373-14,723-15,549 DIVISIONAL Capital expenditure Y/e June 30 ($m) e 2017e 2018e Investing cashflow -32,450-75,110-51,285-49,184-51,881 Retail Banking Services Net interest income 7,307 7,848 8,568 8,841 9,240 Increase in deposits & borrowings 34,489 58,214 37,299 38,726 41,379 Other income 1,695 1,754 1,877 1,990 2,110 Increase in other liabilities ,136 3,265 5,891 5,629 Total banking income 9,002 9,602 10,445 10,831 11,350 Equity raised ,476 1,832 1,916 Operating expenses -3,173-3,276-3,420-3,427-3,508 Other -4,951-6,253-6,853-7,365-7,698 Impairment expenses Financing cashflow 29,545 72,680 40,187 39,084 41,225 Net profit before tax 5,247 5,700 6,406 6,661 6,988 Corporate tax expense -1,569-1,706-1,917-1,993-2,091 Net change in cash 5,775 6,707-1, Cash net profit after tax 3,678 3,994 4,489 4,667 4,897 Cash at end of period 26,409 33,116 31,587 31,587 31,587 Home loans 271, , , , ,799 Consumer loans 16,387 16,897 17,900 19,234 20,652 BALANCE SHEET Deposits 196, , , , ,827 Y/e June 30 ($m) e 2017e 2018e Deposits non bearing interest 7,222 8,123 8,625 9,228 9,874 Cash and liquid assets 26,409 33,116 31,587 31,587 31,587 Divisional gross loans 598, , , , ,485 B&PB / IB&M Provisions -3,906-3,649-4,170-4,816-5,357 Net interest income 4,099 4,367 4,668 4,792 5,049 Divisional IEA 48,328 35,613 37,633 39,724 41,948 Other income 2,026 2,153 2,176 2,299 2,442 Other IEA & other loans 80, , , , ,317 Total banking income 6,125 6,520 6,844 7,091 7,491 Intangibles 9,792 9,970 10,018 10,018 10,018 Operating expenses -2,281-2,398-2,493-2,447-2,494 PP&E 2,816 2,838 3,371 3,473 3,578 Impairment expenses Insurance assets 15,142 14,088 15,497 16,737 17,741 Net profit before tax 3,546 3,803 3,901 4,099 4,371 Other assets 13,843 12,569 10,999 10,999 10,999 Corporate tax expense ,023-1,022-1,074-1,145 Total assets 791, , , ,434 1,024,315 Cash net profit after tax 2,573 2,780 2,879 3,025 3,225 Loans 181, , , , ,910 Divisional deposits & borrowings 483, , , , ,438 Other IEA 43,524 28,981 30,430 31,799 33,230 Other borrowings 226, , , , ,092 IBL 181, , , , ,078 Other liabilities 32,193 29,847 26,112 26,112 26,112 Deposits non bearing interest 5,081 32,169 34,421 36,830 39,408 Total liabilities 742, , , , ,642 Wealth Management Ordinary share capital 27,036 27,619 34,095 35,927 37,843 Funds management income 1,699 1,846 1,947 2,040 2,142 Other equity instruments Insurance income Reserves 2,009 2,345 2,554 2,554 2,554 Total operating income 2,274 2,349 2,529 2,668 2,808 Retained profits 18,827 21,528 24,091 26,826 29,784 Volume expenses Minority interests Operating expenses ,116-1,158-1,193-1,229 Total shareholders' equity 49,348 52,993 62,233 66,800 71,673 Net profit before tax Corporate tax expense Total sh. equity & liabs. 791, , , ,434 1,024,315 Investment experience Cash net profit after tax WANOS - statutory (m) 1,608 1,618 1,691 1,725 1,750 FUA 253, , , , ,046 WANOS - cash (m) 1,611 1,620 1,693 1,727 1,752 New Zealand PROFITABILITY RATIOS Net interest income 1,378 1,527 1,530 1,602 1,661 Y/e June e 2017e 2018e Other income Return on assets 1.1% 1.1% 1.0% 1.1% 1.1% Total banking income 1,570 1,813 1,901 2,000 2,074 Return on equity 18.7% 18.2% 16.6% 15.9% 15.6% Funds management income Leverage ratio 4.8% 4.8% 5.5% 5.6% 5.8% Insurance income Net interest margin 2.14% 2.09% 2.06% 2.05% 2.05% Total operating income 1,832 2,116 2,231 2,349 2,441 Cost / income ratio 43% 43% 42% 40% 39% Operating expenses Cost / average assets 1.20% 1.16% 1.15% 1.09% 1.06% Impairment expenses Growth in operating income 7% 6% 6% 4% 5% Net profit before tax 976 1,172 1,291 1,400 1,469 Growth in operating expenses 5% 6% 5% 0% 2% Corporate tax expense Jaws 2% 0% 2% 4% 3% Minority interests Investment experience ASSET QUALITY Cash net profit after tax ,025 1,076 Y/e June e 2017e 2018e Loans 52,153 59,592 62,366 64,875 67,470 Impairment expense / GLA 0.16% 0.15% 0.18% 0.21% 0.23% Other IEA 4,804 6,632 7,203 7,925 8,717 Impairment expense / RWA 0.28% 0.27% 0.28% 0.31% 0.35% Deposits 34,454 42,492 44,050 46,263 48,576 Total provisions ($m) 3,906 3,649 4,170 4,816 5,357 Other IBL 14,514 13,883 13,706 13,709 13,709 Total provisions / RWA 1.16% 0.99% 0.96% 1.00% 1.05% Indiv ass prov / gross imp assets 33% 31% 33% 33% 34% IBL / IEA 98% 99% 98% 98% 97% Total provisions + GRCL / RWA 1.16% 0.99% 0.96% 1.00% 1.05% SOURCE: BELL POTTER SECURITIES ESTIMATES Page 11
12 Recommendation structure Buy: Expect >15% total return on a 12 month view. For stocks regarded as Speculative a return of >30% is expected. Research Team Staff Member TS Lim Industrials Sam Haddad John O Shea Title/Sector Head of Research Industrials Industrials Phone tslim shaddad joshea Hold: Expect total return between -5% Chris Savage Industrials csavage and 15% on a 12 month view Jonathan Snape Industrials jsnape Sell: Expect <-5% total return on a 12 month view Sam Byrnes John Hester Tanushree Jain Industrials Healthcare Healthcare/Biotech sbyrnes jhester tnjain Speculative Investments are either start-up enterprises with nil or only prospective operations or recently commenced operations with only forecast cash flows, or companies that have commenced operations or have been in operation for some time but have only forecast cash flows and/or a stressed balance sheet. Such investments may carry an Financials TS Lim Lafitani Sotiriou Resources Peter Arden David Coates Quantitative Tim Piper Hamish Murray Banks/Regionals Diversified Resources Resources Associate Analyst Associate Analyst tslim lsotiriou parden dcoates tpiper hmurray exceptionally high level of capital risk and volatility of returns. Bell Potter Securities Limited ACN Level 38, Aurora Place 88 Phillip Street, Sydney 2000 Telephone The following may affect your legal rights. Important Disclaimer: This document is a private communication to clients and is not intended for public circulation or for the use of any third party, without the prior approval of Bell Potter Securities Limited. In the USA and the UK this research is only for institutional investors. It is not for release, publication or distribution in whole or in part to any persons in the two specified countries. In Hong Kong this research is being distributed by Bell Potter Securities (HK) Limited which is licensed and regulated by the Securities and Futures Commission, Hong Kong. This is general investment advice only and does not constitute personal advice to any person. Because this document has been prepared without consideration of any specific client s financial situation, particular needs and investment objectives ( relevant personal circumstances ), a Bell Potter Securities Limited investment adviser (or the financial services licensee, or the representative of such licensee, who has provided you with this report by arraignment with Bell Potter Securities Limited) should be made aware of your relevant personal circumstances and consulted before any investment decision is made on the basis of this document. While this document is based on information from sources which are considered reliable, Bell Potter Securities Limited has not verified independently the information contained in the document and Bell Potter Securities Limited and its directors, employees and consultants do not represent, warrant or guarantee, expressly or impliedly, that the information contained in this document is complete or accurate. Nor does Bell Potter Securities Limited accept any responsibility for updating any advice, views opinions, or recommendations contained in this document or for correcting any error or omission which may become apparent after the document has been issued. Except insofar as liability under any statute cannot be excluded. Bell Potter Securities Limited and its directors, employees and consultants do not accept any liability (whether arising in contract, in tort or negligence or otherwise) for any error or omission in this document or for any resulting loss or damage (whether direct, indirect, consequential or otherwise) suffered by the recipient of this document or any other person. Disclosure of interest: Bell Potter Securities Limited, its employees, consultants and its associates within the meaning of Chapter 7 of the Corporations Law may receive commissions, underwriting and management fees from transactions involving securities referred to in this document (which its representatives may directly share) and may from time to time hold interests in the securities referred to in this document. TS Lim owns 3,734 shares in CBA. ANALYST CERTIFICATION Each research analyst primarily responsible for the content of this research report, in whole or in part, certifies that with respect to each security or issuer that the analyst covered in this report: (1) all of the views expressed accurately reflect his or her personal views about those securities or issuers and were prepared in an independent manner, including with respect to Bell Potter, and (2) no part of his or her compensation was, is, or will be, directly or indirectly, related to the specific recommendations or views expressed by that research analyst in the research report. Page 12
ANZ Bank (ANZ) Unquestionably strong 1Q17. Healthy Jaws, safe to go back in the water SOURCE: BELL POTTER SECURITIES ESTIMATES
17 February 2017 Analyst TS Lim 612 8224 2810 Authorisation Chris Savage 612 8224 2835 ANZ Bank (ANZ) Unquestionably strong 1Q17 Recommendation Buy (Hold) Price $30.21 Target (12 months) $33.25 (previously
More informationANZ Banking Group (ANZ)
1 May 2018 Analyst TS Lim 612 8224 2810 Authorisation Chris Savage 612 8224 2835 Recommendation Buy (unchanged) Price $27.47 Target (12 months) $30.20 (unchanged) GICS Sector Banks Expected Return Capital
More informationPlatinum Asset Management (PTM)
24 February 2017 Analyst Lafitani Sotiriou 613 9235 1668 Associate Analyst James Filius 613 9235 1612 Authorisation TS Lim 612 8224 2810 Recommendation Hold (unchanged) Price $5.10 Target (12 months) $4.90
More informationPerpetual (PPT) Oversold, upgrade to Buy. Over 6% yield, with upside in market rally. Quarterly highlights. Earnings revisions
16 April 2018 Analyst Lafitani Sotiriou 613 9235 1668 Authorisation TS Lim 612 8224 2810 Perpetual (PPT) Oversold, upgrade to Buy Recommendation Buy (Hold) Price $42.09 Target (12 months) $47.50 (previously
More informationNational Australia Bank (NAB)
6 February 2017 Analyst TS Lim 612 8224 2810 Authorisation Chris Savage 612 8224 2835 Recommendation Buy (unchanged) Price $30.39 Target (12 months) $32.50 (previously $30.00) Expected Return Capital growth
More informationAuswide Bank (ABA) There are no tricks in plain and simple faith. 24 August : Underlying NPAT $17m, final dividend 18cps
24 August 2018 TS Lim 612 8224 2810 Authorisation Tim Piper 612 8224 2825 Recommendation Buy (unchanged) Price $5.71 Target (12 months) $6.20 (previously $5.80) GICS Sector Banks Expected Return Capital
More informationOneVue Holdings (OVH)
24 April 2018 Analyst Lafitani Sotiriou 613 9235 1668 Authorisation Peter Arden 613 9235 1833 OneVue Holdings (OVH) Restructured and focused Recommendation Buy (unchanged) Price $0.745 Target (12 months)
More informationOneVue Holdings (OVH)
7 August 2017 Analyst Lafitani Sotiriou 613 9235 1668 Associate Analyst James Filius 613 9235 1612 Authorisation TS Lim 612 8224 2810 OneVue Holdings (OVH) FY17 result to show cost-out progress Recommendation
More informationBWX Limited (BWX) SOURCE: BELL POTTER SECURITIES ESTIMATES
9 February 2017 Analyst John O'Shea 613 9235 1633 Authorisation John Hester 612 8224 2871 Recommendation Buy (unchanged) Price $4.80 Target (12 months) $5.73 (unchanged) Expected Return Capital growth
More informationAdacel Technologies (ADA)
9 November 2018 Chris Savage 612 8224 2835 Authorisation TS Lim 612 8224 2810 Adacel Technologies (ADA) Bad, but not that bad Recommendation Buy (unchanged) Price $0.88 Target (12 months) $1.50 (previously
More informationNanosonics (NAN) Preparing for new international markets. Maintain Hold, price target amended to $3.20 SOURCE: BELL POTTER SECURITIES ESTIMATES
21 February 2017 Analyst John Hester 612 8224 2871 Authorisation TS Lim 612 8224 2810 Nanosonics (NAN) Growth Slowly Emerging In Europe Recommendation Hold (unchanged) Price $2.80 Target (12 months) $3.20
More informationNational Australia Bank (NAB)
29 March 2016 Analyst TS Lim 612 8224 2810 Authorisation Chris Savage 612 8224 2835 Recommendation Buy (unchanged) Price $25.62 Target (12 months) $29.50 (unchanged) Expected Return Capital growth 15.1%
More informationMayne Pharma (MYX) Yet Another Transformational Acquisition. FY16 Earnings Confirmed. The company did not provide guidance in respect of FY17.
29 June 2016 Analyst John Hester 612 8224 2871 Authorisation TS Lim 612 8224 2810 Mayne Pharma (MYX) Merger Fallout Creates Opportunity Recommendation Buy (unchanged) Price $1.485 Target (12 months) $1.89
More informationChallenger (CGF) Expanding the potential. A broader and more robust business emerging. Earnings revisions SOURCE: BELL POTTER SECURITIES ESTIMATES
14 February 2017 Analyst Lafitani Sotiriou 613 9235 1668 Associate Analyst James Filius 613 9235 1612 Authorisation TS Lim 612 8224 2810 Challenger (CGF) Expanding the potential Recommendation Buy (unchanged)
More informationSurfStitch (SRF) Shaping the Surf industry. Acquisition in Product drives credibility. however we have some concerns
26 November 20 Analyst Sam Byrnes 612 8224 2886 Authorisation Chris Savage 612 8224 2835 SurfStitch (SRF) Shaping the Surf industry Recommendation Buy (unchanged) Price $2.06 Target (12 months) $2.65 (previously
More informationNanosonics (NAN) Summary of 2Q17 Cash Flows SOURCE: BELL POTTER SECURITIES ESTIMATES
16 January 2017 Analyst John Hester 612 8224 2871 Authorisation TS Lim 612 8224 2810 Nanosonics (NAN) US Market Continues To Expand Recommendation Hold (unchanged) Price $3.16 Target (12 months) $3.28
More informationCyclopharm (CYC) Entry to US market inching closer. Maintain Buy Recommendation SOURCE: BELL POTTER SECURITIES ESTIMATES
Analyst John Hester 612 8224 2871 Cyclopharm (CYC) 5 March 2018 Speculative See key risks on Page 4 and Biotechnology Risk Warning on Page 7. Speculative securities may not be suitable for Retail Clients.
More informationOsprey (OSP) FY16 EBITDA Loss In Line. OSP has US$21.8m of cash as at 31 December Maintain Buy Rating And Valuation at $0.55
27 February 2017 Analyst John Hester 612 8224 2871 Authorisation Tanushree Jain 612 8224 2849 Recommendation Buy (unchanged) Price $0.415 Valuation $0.55 (unchanged) Risk Speculative GICS Sector Healthcare
More informationIPH Limited (IPH) Buy at the bottom
29 March 2017 Analyst Sam Haddad 612 8224 2819 Authorisation TS Lim 612 8224 2810 IPH Limited (IPH) Buy at the bottom Recommendation Buy (unchanged) Price $4.76 Target (12 months) $7.90 (unchanged) Expected
More informationFortescue Metals Group Ltd (FMG)
3 March 2017 Analyst David Coates 612 8224 2887 Authorisation Peter Arden 613 9235 1833 Fortescue Metals Group Ltd (FMG) All about the iron ore price Recommendation Sell (unchanged) Price $6.62 Target
More informationWestgold Resources (WGX)
3 September 2018 Analyst Peter Arden 613 9235 1833 Authorisation David Coates 612 8224 2887 Recommendation Buy (unchanged) Price $1.36 Target (12 months) $2.15 (unchanged) Expected Return Capital growth
More informationAeon Metals Limited (AML)
Analyst David Coates 612 8224 2887 Authorisation Stuart Howe 613 9235 1856 Speculative See key risks on Page 4 Speculative securities may not be suitable for retail clients 22 March 2019 Aeon Metals Limited
More informationProfit Announcement For the full year ended 30 June 2013
Profit Announcement For the full year ended 30 June 2013 COMMONWEALTH BANK OF AUSTRALIA ACN 123 123 124 14 AUGUST 2013 FIND OUT MORE VIA OUR APP ASX Appendix 4E Results for announcement to the market (1)
More informationBank Note$ Mentioned in despatches. 7 March December 2017 reporting wrap: Fundamentals sound
7 March 2018 Analyst TS Lim 612 8224 2810 Authorisation Chris Savage 612 8224 2835 Bank Note$ Mentioned in despatches Stock Price Target Rating ANZ $28.58 $32.50 Buy CBA $75.69 $83.90 Buy NAB $30.10 $34.20
More informationPremier Investments (PMV)
16 March 2018 Analyst Sam Haddad 612 8224 2819 Authorisation Tim Piper 612 8224 2825 Premier Investments (PMV) Key growth pillars all strong Recommendation Buy (unchanged) Price $15.27 Target (12 months)
More informationPeet Bonds (PPCHA) A yield uplift from fixed rate senior debt
4 May 2016 Analysts Damien Williamson 613 9235 1958 Barry Ziegler 613 9235 1848 (PPCHA) Authorisation TS Lim 612 8224 2810 Fixed Income Issue overview Issuer Issue ASX code Peet PPCHA Face value $100 Estimated
More informationResults Presentation For the half year ended 31 December 2009
100 YEARS OF BANKING ON AUSTRALIA S FUTURE Media Presentation FOR THE HALF YEAR ENDED 31 DECEMBER 2011 Ian Narev Chief Executive Officer Results Presentation For the half year ended 31 December 2009 10
More informationMetals X Limited (MLX)
16 July 2018 Analyst Peter Arden 613 9235 1833 Authorisation David Coates 612 8224 2887 Recommendation Buy (unchanged) Price $0.655 Target (12 months) $0.95 (previously $0.98) Expected Return Capital growth
More informationTalisman Mining Ltd (TLM)
Analyst Peter Arden 613 9235 1833 Authorisation David Coates 612 8224 2887 Recommendation Buy (unchanged) Price $0.41 Valuation $0.88 (previously $1.00) Risk Speculative Expected Return Capital growth
More informationBreaker Resources NL (BRB)
David Coates 612 8224 2887 Authorisation Peter Arden 613 9235 1833 Speculative See key risks on Page 6. Speculative securities may not be suitable for retail clients 8 February 2019 Breaker NL (BRB) More
More informationInvestor Presentation
Determined to be better than we ve ever been. Ralph Norris CHIEF EXECUTIVE OFFICER Investor Presentation 16 November 2010 Commonwealth Bank of Australia ACN 123 123 124 Disclaimer The material that follows
More informationMetals X Limited (MLX)
5 September 2018 Analyst Peter Arden 613 9235 1833 Authorisation David Coates 612 8224 2887 Recommendation Buy (unchanged) Price $0.515 Target (12 months) $0.90 (previously $0.95) Expected Return Capital
More informationProfit Announcement. For the full year ended 30 June 2017
Profit Announcement For the full year ended 30 June 2017 Commonwealth Bank of Australia ACN 123 123 124 9 August 2017 ASX Appendix 4E Results for announcement to the market (1) Report for the year ended
More informationMetals X Limited (MLX)
19 April 2018 Analyst Peter Arden 613 9235 1833 Authorisation David Coates 612 8224 2887 Recommendation Buy (unchanged) Price $0.76 Target (12 months) $0.98 (previously $1.00) Expected Return Capital growth
More information7.0% fully franked yield (expected 10.0% gross): Fixed until Nov 2018 reset date
6 July 2012 Analysts Damien Williamson 613 9235 1958 Barry Ziegler 613 9235 1848 William Spraggett 613 9235 1733 Whitefield Resettable Preference Shares (WHFPB) Authorisation John Gleeson 612 9255 7220
More informationGalaxy Resources Ltd (GXY)
Analyst Peter Arden 613 9235 1833 Authorisation Duncan Hughes 618 9326 7667 Recommendation Buy (unchanged) Price $1.835 Valuation $3.35 (unchanged) -------------- Risk Speculative Expected Return Capital
More informationFortescue Metals Group (FMG)
30 October 2015 Analyst David Coates 612 8224 2887 Authorisation John Hester 612 8224 2871 Recommendation Buy (Hold) Price $2.09 Target (12 months) $2.40 (unchanged) Expected Return Capital growth 14.8%
More informationMacquarie Group Capital Notes 2 (MQGPB) * MANDATORY CONVERSION IS SUBJECT TO SATISFYING THE MANDATORY CONVERSION CONDITIONS
23 November 2015 Analysts Damien Williamson 613 9235 1958 Barry Ziegler 613 9235 1848 Authorisation Macquarie Group Capital Notes 2 (MQGPB) TS Lim 612 8224 2810 Fixed Interest Issue overview Issuer Issue
More informationOsprey Medical (OSP)
18 October 2017 Analyst John Hester 612 8224 2871 Authorisation TS Lim 612 8224 2810 Osprey Medical (OSP) Harvey and Irma Curtail Growth Speculative See key risks on Page 5 and Biotechnology Risk Warning
More informationFor personal use only
For personal use only Profit Announcement FOR THE FULL YEAR ENDED 30 JUNE 2014 COMMONWEALTH BANK OF AUSTRALIA ACN 123 123 124 13 AUGUST 2014 ASX Appendix 4E Results for announcement to the market (1) Report
More informationBendigo and Adelaide Bank
AUSTRALIA BEN AU Price (at CLOSE#, 17 Aug 2012) Neutral A$8.69 Volatility index Low 12-month target A$ 9.28 12-month TSR % +14.0 Valuation - DCF (WACC 12.1%) A$ 8.28 GICS sector Banks Market cap A$m 3,447
More informationRide the recovery. Figure 1: Trading margins on debt and equity securities. (prior to exchange) over BBSW Mand Conv* Call
17 May 2016 Analysts Damien Williamson 613 9235 1958 Barry Ziegler 613 9235 1848 Authorisation TS Lim 612 8224 2810 Fixed Income Issue overview Issuer Issue ASX code BELL POTTER SECURITIES LIMITED ACN
More informationLong-term strategy delivers continuing customer satisfaction and profit growth
Long-term strategy delivers continuing customer satisfaction and profit growth Highlights of 2015 Result Statutory net profit after tax (NPAT) of $9,063 million up 5 per cent on prior year (1) (2) ; Cash
More informationGalaxy Resources Ltd (GXY)
27 March 2018 Analyst Peter Arden 613 9235 1833 Authorisation Duncan Hughes 618 9326 7667 Galaxy Resources Ltd (GXY) Mt Cattlin doing what it is meant to Recommendation Buy Price $3.16 Price Target $4.75
More informationPresentation of Full Year Results for period ended 30 June 2004
Presentation of Full Year Results for period ended 30 June 2004 David Murray Chief Executive Officer Michael Cameron Chief Financial Officer 11 August 2004 www.commbank.com.au Disclaimer The material that
More informationTech Sector. Updated key sells: None. Company Ticker Share price at Market Year end 22-Mar-17 cap FY17a/CY17e FY18e/CY18e FY17a/CY17e FY18e/CY18e
22 March 2017 Analyst Chris Savage 612 8224 2835 Authorisation TS Lim 612 8224 2810 Tech Sector Key picks unchanged: IRI, APX, ADA & IFM Stock Price Target Rating ADA $2.37 $3.25 Buy ALU $7.41 $7.90 Hold
More informationBreaker Resources NL (BRB)
Analyst David Coates 612 8224 2887 Authorisation Peter Arden 613 9235 1833 Recommendation Buy (unchanged) Price $0.315 Valuation $0.96 (previously $1.30) Risk Speculative GICS Sector Materials Expected
More informationEarnings and target price revision. Price catalyst. Catalyst: 1H14 result in February Action and recommendation
AUSTRALIA CBA AU Price (at 06:10, 10 Sep 2013 GMT) Neutral A$73.63 Valuation A$ - DCF (WACC 10.3%, beta 1.0, ERP 5.0%, RFR 5.5%) 50.40 12-month target A$ 66.15 12-month TSR % -5.0 Volatility Index Low
More informationBasel II Pillar 3. Capital Adequacy and Risk Disclosures as at 31 December Determined to be better than we ve ever been.
Determined to be better than we ve ever been. Basel II Pillar 3 Capital Adequacy and Risk Disclosures as at 31 December 2010 Commonwealth bank of Australia ACN 123 123 124 Table of Contents 1 Introduction
More informationWestpac 2009 Full Year Results
Westpac 2009 Full Year Results Gail Kelly Chief Executive Officer Westpac Banking Corporation ABN 33 007 457 141 Key areas of focus in 2009 Position the Group strongly through the GFC and economic downturn
More informationMedia Presentation. Results Presentation FOR THE FULL YEAR ENDED 30 JUNE Ian Narev Chief Executive Officer. 10 February 2010
Media Presentation FOR THE FULL YEAR ENDED 30 JUNE 2012 Results Presentation Ian Narev Chief Executive Officer For the half year ended 31 December 2009 10 February 2010 Commonwealth Bank of Australia ACN
More informationFor personal use only
17 February 2017 The Manager Company Announcements Australian Securities Exchange 20 Bridge Street Sydney NSW 2000 MyState Limited Correction to Investor Presentation Please be advised that an amendment
More informationValue at the top end. Figure 1: Trading margins on debt and equity securities
17 February 2012 Analysts Damien Williamson 613 9235 1958 Barry Ziegler 613 9235 1848 Authorisation Steve Goldberg 612 8224 2809 Westpac Convertible Preference Shares (WBCPC) Fixed Interest Issue overview
More informationWestgold Resources (WGX)
7 February 2017 Analyst Peter Arden 613 9235 1833 Authorisation David Coates 612 8224 2887 Recommendation Buy (unchanged) Price $2.25 Target (12 months) $2.60 Expected Return Capital growth 15.6% Dividend
More informationPROFIT ANNOUNCEMENT FOR THE FULL YEAR ENDED 30 JUNE 2016 WHEN WE BELIEVE WE CAN,.
PROFIT ANNOUNCEMENT FOR THE FULL YEAR ENDED 30 JUNE 2016 WHEN WE BELIEVE WE CAN,. COMMONWEALTH BANK OF AUSTRALIA ACN 123 123 124 10 AUGUST 2016 ASX Appendix 4E Results for announcement to the market (1)
More informationCOMMONWEALTH BANK OF AUSTRALIA DELIVERS ANOTHER GOOD RESULT
COMMONWEALTH BANK OF AUSTRALIA DELIVERS ANOTHER GOOD RESULT Result underpinned by successful execution of strategic initiatives Highlights of 2011 Result Statutory NPAT of $6,394 million up 13 percent
More informationNational Australia Bank
AUSTRALIA NAB AU Price (at 08:23, 03 Jul 2012 GMT) Outperform A$23.68 Volatility index Low 12-month target A$ 27.66 12-month TSR % +24.9 Valuation A$ - DCF (WACC 12.6%, beta 1.0, ERP 5.0%, RFR 5.8%) 25.14
More informationBUY SHARE PRICE CASH EARNINGS ($M) COMPANY DATA & RATIOS
BUY 0.11 0.39 0.69 SHARE PRICE CASH EARNINGS ($M) COMPANY DATA & RATIOS CONTENTS Competitors Products Sales channels Pricing Model INVESTMENT THESIS COMPANY OVERVIEW INDUSTRY OVERVIEW COMPETITORS BOARD
More informationPremier Investments (PMV)
4 April 2017 Analyst Sam Haddad 612 8224 2819 Authorisation TS Lim 612 8224 2810 Premier Investments (PMV) The Myers touch Recommendation Buy (unchanged) Price $14.20 Target (12 months) $17.65 (previously
More informationProfit Announcement. For the six months ended 31 March 2007
Profit Announcement For the six months ended 3 March 2007 Incorporating the requirements of Appendix 4D This interim profit announcement has been prepared for distribution in the United States of America
More informationProfit Announcement (U.S. Version) Half Year ended 31 December 2008
Profit Announcement (U.S. Version) Half Year ended 31 December 2008 ASX Appendix 4D Results for announcement to the market (1) Report for the half year ended 31 December 2008 $M Revenue from ordinary activities
More informationNAB 2015 Half Year Results
800 Bourke Street Docklands VIC 3008 AUSTRALIA www.nabgroup.com Thursday, 7 May 2015 ASX Announcement NAB 2015 Half Year Results Executing our strategy, building a stronger bank Highlights Cash earnings
More informationFor personal use only
Media Release CBA FY17 Results For the full year ended 30 June 2017¹ Reported 9 August 2017 Commonwealth Bank delivers for Australia CEO Comment: Ian Narev Commonwealth Bank s performance this year has
More information1H19 RESULTS PRESENTATION
1H19 RESULTS PRESENTATION 11 APRIL 2019 Half year ended 28 February 2019 Anthony Rose Interim CEO Matt Baxby Chief Financial Officer Anthony Rose Interim CEO 2 Niche growth, asset quality and capital remain
More informationAustralian Banks. Funding markets open for now
AUSTRALIA Weekly performance 4% 2% % -2% -4% -6% -8% -1% Source: IRESS, August 212 Rolling monthly performance 8% 6% 4% 2% % -2% -4% -6% Source: IRESS, August 212 Rolling yearly performance % 15% 5% -5%
More informationParagon Care (PGC) Big Boxes, Big Opportunity. Capitalising on the burgeoning healthcare sector. Price leadership through quality
26 September 2014 Analyst John Hester 612 8224 2871 Authorisation TS Lim 612 8224 2810 Paragon Care (PGC) Big Boxes, Big Opportunity Recommendation Buy (Initiation) Price $0.33 Target (12 months) $0.38
More informationAustralian Banks. Pre-Reporting Form Guide AUSTRALIA. Event. Impact. Outlook
AUSTRALIA MRE vs Consensus MQG FY15 Consensus FY15 Date Profit EPS DPS Profit EPS DPS BEN 10-Aug 439 92 67 434 92 67 CBA 12-Aug 9,289 557 420 9,116 554 419 Source: Factset, Macquarie Research, August 2015
More informationHALF YEAR RESULTS 2017
HALF YEAR RESULTS Incorporating the requirements of Appendix 4D The half year results announcement incorporates the half year report given to the Australian Securities Exchange (ASX) under Listing Rule
More informationSt George Mining Ltd (SGQ)
Analyst Peter Arden 613 9235 1833 Authorisation Duncan Hughes 618 9326 7667 Recommendation Buy (unchanged) Price $0.225 Valuation $0.30 (previously $0.26) Risk Speculative Expected Return Capital growth
More informationInvestor presentation
FY17 INVESTOR PRESENTATION 1 18 August 2017 Investor presentation FY17 Agenda FY17 INVESTOR PRESENTATION 1. Overview & strategic landscape Melos Sulicich CEO & Managing Director 2. Financial results David
More informationPioneer Credit (PNC)
23 June 2014 Analyst Sam Byrnes 612 8224 2886 Authorisation Chris Savage 612 8224 2835 Pioneer Credit (PNC) Helping not chasing Recommendation Buy (Initiation) Price $1.55 Target (12 months) $1.80 Expected
More informationChallenger. Normalised margin trends expected to decline. Earnings and target price revision. Price catalyst. Action and recommendation
1H13E 2H13E 1H14E 2H14E 1H15E 2H15E AUSTRALIA CGF AU Price (at CLOSE#, 20 Aug 2012) Outperform A$3.76 Volatility index Low 12-month target A$ 4.57 12-month TSR % +26.4 Valuation - Sum of Parts A$ 4.57
More informationStrike Energy Ltd (STX)
Analyst Peter Arden 613 9235 1833 Authorisation Stuart Howe 613 9235 1782 Recommendation Buy (unchanged) Price $0.115 Valuation $0.26 (previously $0.23) Risk Speculative Expected Return Capital growth
More informationOperating momentum across all divisions, cash earnings up 4 per cent
Operating momentum across all divisions, cash earnings up 4 per cent Interim Result Highlights Half year to 31 December 2015. Unless otherwise indicated, all comparisons are to prior comparative period.
More informationAustralian Banks. If it s too good to be true AUSTRALIA. Event. Impact. Outlook. Impact of repricing and capital from additional 10% investor RWA
CBA CBA CBA CBA AUSTRALIA Changes to lending rates (bps) bps Owner Occupier Investor P&I IO P&I IO 0 20 25 36 CBA 3 25 24 26 7 7 25 25 3 8 23 28 BEN 0 0 25 25 Source: Company data, Macquarie research,
More informationMetals X Limited (MLX)
1 November 2016 Analyst Peter Arden 613 9235 1833 Authorisation David Coates 612 8224 2887 Recommendation Buy (unchanged) Price $1.38 Target (12 months) $2.10 (unchanged) Expected Return Capital growth
More informationIOOF. Positive flows in 1Q17. FUM and Net Flows for September Qtr Source: Company data, Macquarie Research, Oct 2016.
AUSTRALIA IFL AU Price (at 06:35, 26 Oct 2016 GMT) Outperform A$8.34 Valuation A$ - DCF (WACC 8.8%, beta 1.1, ERP 5.0%, RFR 3.3%) 8.74 12-month target A$ 9.00 12-month TSR % +14.3 Volatility Index Low/Medium
More informationFor personal use only
CBA 3Q18 Trading Update For the quarter ended 31 March 2018 1. Reported 9 May 2018. All comparisons are to the average of the two quarters of the first half of FY18 unless noted otherwise. Summary Unaudited
More informationMesoblast (MSB) GVHD granted Fast Track, should benefit ongoing negotiations with Mallinckrodt
7 March 2017 Analyst Tanushree Jain 612 8224 2849 Authorisation Chris Savage 612 8224 2835 Recommendation Buy (unchanged) Price $1.90 Valuation $3.22 (previously $3.17) Risk Speculative GICS Sector Pharmaceuticals
More informationFinancial results. Full year ended 30 June Nick Hawkins Chief Financial Officer. Peter Harmer Managing Director and Chief Executive Officer
Financial results Full year ended 30 June 2017 Peter Harmer Managing Director and Chief Executive Officer Nick Hawkins Chief Financial Officer 23 August 2017 Overview Peter Harmer Managing Director and
More informationWestpac Banking Corporation
Westpac Banking Corporation David Morgan Chief Executive Officer March 2007 Westpac Banking Corporation at a glance Australia s first bank est. 1817 Top 50 bank globally 1 Consistent earnings growth Strong
More informationAustralia Banks. A little ray of sunshine AUSTRALIA. Event. Impact. Outlook. 16 April 2013 Macquarie Securities (Australia) Limited
AUSTRALIA Loan growth driven out of WA & VIC with NSW & QLD growing below system % 2.5% 25% 20% 1.5% 15% 10% 0.5% 5% 0% -0.5% -5% - -10% -1.5% -15% - -20% -2.5% -25% 1992 1995 1998 2001 2004 2007 2010
More informationBank of Queensland. Macquarie Connections Australia Conference 7 May 2009
Bank of Queensland 7 May 2009 Difficult environment... Our response The Environment... Going forward Economic growth slowing Unemployment rising towards 7-8%... Plan for economy to bottom in late 2010
More informationUBS Investment Research Brambles Limited
UBS Investment Research Brambles Limited FY12 result: strong revenue momentum Result highlights strong revenue momentum Brambles FY12 result was slightly ahead of expectations, revealing 11% underlying
More informationFOR THE HALF-YEAR ENDED 28 FEBRUARY Bank of Queensland Limited ABN AFSL No
FOR THE HALF-YEAR ENDED 28 FEBRUARY 2017 Bank of Queensland Limited ABN 32 009 656 740. AFSL No 244616. JON SUTTON Managing Director & CEO ANTHONY ROSE Chief Financial Officer JON SUTTON Managing Director
More informationANZ Capital Notes Offer
ANZ Capital Notes Offer AUSTRALIA AND NEW ZEALAND BANKING GROUP LIMITED 2 July 2013 Disclaimer Australia and New Zealand Banking Group Limited (ABN 11 005 357 522) ("ANZ") is the issuer of the ANZ Capital
More informationCOMMONWEALTH BANK OF AUSTRALIA DELIVERS CASH EARNINGS GROWTH OF 8 PER CENT FOR FIRST HALF Highlights of the 2015 Interim Result
COMMONWEALTH BANK OF AUSTRALIA DELIVERS CASH EARNINGS GROWTH OF 8 PER CENT FOR FIRST HALF 2015 Highlights of the 2015 Interim Result Statutory NPAT of $4,535 million up 8 per cent; (1,2,3) Cash NPAT of
More informationBank of Queensland Full year results 31 August Bank of Queensland Limited ABN AFSL No
Bank of Queensland Full year results 31 August 2013 Bank of Queensland Limited ABN 32 009 656 740. AFSL No 244616. Agenda Result overview Stuart Grimshaw Managing Director and CEO Financial detail Anthony
More informationTABLE OF CONTENTS Interim Profit Announcement 2005
Profit Announcement For the six months ended 3 March 2005 This interim profit announcement has been prepared for distribution in the United States of America TABLE OF CONTENTS Interim Profit Announcement
More informationASX Announcement CBA 1H18 Result
ASX Announcement CBA Result For the half year ended 31 December 2017 Reported 7 February 2018 Guide to CBA s financial results CBA s net profit after tax is disclosed on both a statutory and cash basis,
More informationANZ Convertible Preference Shares (CPS) Australia and New Zealand Banking Group Limited August 2008
ANZ Convertible Preference Shares (CPS) Australia and New Zealand Banking Group Limited August 2008 1 Disclaimer Australia and New Zealand Banking Group Limited (ABN 11 005 357 522) ("ANZ") is the proposed
More informationAUSTRALIA AND NEW ZEALAND BANKING GROUP LIMITED ABN
AUSTRALIA AND NEW ZEALAND BANKING GROUP LIMITED ABN 11 005 357 522 Media Release For Release: 2 May 2012 ANZ 2012 Half Year Result - super regional strategy delivers solid performance, higher dividend
More informationINVESTOR PRESENTATION
INVESTOR PRESENTATION FULL YEAR FY2018 17 August 2018 AGENDA FY18 INVESTOR PRESENTATION 1. Highlights & strategy Melos Sulicich Managing Director & CEO 2. Financial results David Harradine Chief Financial
More informationAMP. Earnings and target price revision. No change. Price catalyst. Action and recommendation
AUSTRALIA AU Price (at CLOSE#, 19 Mar 213) Underperform A$5.7 Volatility index Low 12-month target A$ 4.99 12-month TSR % +3.6 Valuation - Sum of Parts A$ 4.68 GICS sector Insurance Market cap A$m 14,855
More informationFY18 RESULTS PERPETUAL LIMITED. Twelve months to 30 June Chris Green Interim Chief Executive Officer. Gillian Larkins Chief Financial Officer
30 August 2018 PERPETUAL LIMITED RESULTS Twelve months to 30 June 2018 Chris Green Interim Chief Executive Officer Gillian Larkins Chief Financial Officer ABN 86 000 431 827 CHRIS GREEN INTERIM CHIEF EXECUTIVE
More informationCommonwealth Bank of Australia Recent Developments
November 24, 2014 Commonwealth Bank of Australia Recent Developments The information set forth below is not complete and should be read in conjunction with the information contained on the Supplementary
More informationPlatinum Asset Management
AUSTRALIA PTM AU Price (at 06:10, 11 Jul 2016 GMT) Neutral A$5.52 Valuation A$ - DCF (WACC 9.3%, beta 1.2, ERP 5.0%, RFR 3.3%) 5.19 12-month target A$ 5.36 12-month TSR % +2.6 Volatility Index Low/Medium
More informationASX Release. 24 April 2018
ASX Release 24 April 2018 Westpac 2018 Interim Financial Results Template The Westpac has today released the template for its 2018 Interim Financial Results. It outlines the changes that will be made in
More informationBasel II Pillar years of banking on Australia s future. Capital Adequacy and risk disclosures as at 31 December FEBRUARY 2012
100 years of banking on Australia s future Basel II Pillar 3 Capital Adequacy and risk disclosures as at 31 December 2011 15 FEBRUARY 2012 Commonwealth bank of Australia ACN 123 123 124 Table of Contents
More informationRalph Norris CHIEF EXECUTIVE OFFICER
Determined to be better than we ve ever been. Ralph Norris CHIEF EXECUTIVE OFFICER Credit Suisse Asian Investment Conference 25 March 2010 Commonwealth Bank of Australia ACN 123 123 124 This page has been
More information